HOME >> MEDICINE >> NEWS
Toward the future of cancer prevention

ial.

Other chemopreventive agents have proven to be effective. M. D. Anderson researchers have found that:

  • A low-dose baby aspirin proved effective as a modest colon cancer chemopreventive. A randomized clinical trial of more than 1,000 participants found it reduced the number of precancerous polyps by 19 percent. Robert Bresalier, M.D., chair of the Department of Gastrointestinal Medicine and Nutrition, helped lead this national effort.
  • Celecoxib, a non-steroidal anti-inflammatory drug (NSAID) known by the trade name Celebrex, reduced the number of colon polyps in people who have familial adenomatous polyposis (FAP), in which hundreds of precancerous polyps form in the colon and rectum. The study, led by researchers at M. D. Anderson and St. Mark's Hospital, London, in collaboration with the National Cancer Institute, led to federal approval of Celebrex for FAP patients.
  • Supplements of selenium and vitamin E unexpectedly reduced the incidence of prostate cancer by up to two-thirds in trials testing them for different cancers. These observations led to the ongoing international Selenium and Vitamin E Cancer Prevention Trial (SELECT) in more than 32,000 patients. M. D. Anderson leaders of SELECT include Lippman and Elise D. Cook, M.D., who led the national effort to recruit minority men, especially African-Americans, who have the highest risk of prostate cancer in the world. Cook's successful campaign resulted in the highest percentage of African-Americans ever recruited to a large-scale cancer prevention trial.
  • The spice curcumin (found in turmeric and curry powders) has shown dramatic results in preventing cancer in animal studies, and has led to clinical studies at M. D. Anderson with patients that have pancreatic cancer or multiple myeloma. A trial with breast cancer patients is expected to begin in 2005. Patients in these trials take curcumin capsules daily.

A number of ongoing chemoprevention tria
'"/>

Contact: Nancy Jensen
nwjensen@mdanderson.org
713-794-1584
University of Texas M. D. Anderson Cancer Center
16-Dec-2005


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. NIH scientists target future pandemic strains of H5N1 avian influenza
2. The Eli and Edythe Broad Foundation invests in gastroenterologys future
3. The future of biofuels is not in corn
4. The future of biofuels is not in corn
5. Inactive kids storing up illness for the future
6. SCAIs Therapies in Evolution showcases exciting future of interventional cardiology
7. Conception date affects babys future academic achievement
8. ASU, Walter Reed researchers create prosthesis of the future
9. Why GNEP cant jump to the future
10. NeuroArm: Navigating the future of surgery
11. IceSAR campaign provides glimpse of future Sentinel-1 images over ice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Toward the future cancer prevention

(Date:1/22/2015)... Liberty University has received accreditation for its ... the Council for Accreditation of Counseling & Related Educational ... Center for Counseling & Family Studies , is under the ... new School of Behavioral Sciences. Prior to the formation of ...
(Date:1/22/2015)... AZ (PRWEB) January 22, 2015 Padre Murphy's ... long supporter of Pro Player Health Alliance (PPHA). ... Padre Murphy's in getting everyone, including NFL greats, treated for ... of the leading groups supporting the cause in the valley. ...
(Date:1/22/2015)... January 23, 2015 AngelWeddingDress, the premier ... 2015 maternity wedding dresses. View website of ... looking for maternity wedding dresses online for a bridal ... with high quality for them. Its maternity wedding dresses ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
(Date:1/23/2015)... EAST SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology ... sites where its Phase I trial of Lixte,s lead compound, ... 5 institutions. John S. Kovach , M.D., ... trial was planned to be completed at a single site. ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
(Date:1/23/2015)... BOSTON , January 23, 2015 ... development company, is delighted to announce that the Malcolm ... Miles Congreve (Vice President of Chemistry), Fiona ... Weir (Chief Executive Officer and co-founder) for the seminal ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
Cached News: